CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0333

Testosterone Cypionate Raw

Filed under Raw Materials. The bureau holds 121 laboratory returns for this compound from 41 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

41 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
BachemCASE #VI-2026-0314 A 4 10.0 9.9 10.0 27 Mar 2026 10 Jun 2026
WuXi TIDESCASE #VI-2026-0335 A 4 10.0 9.9 10.0 12 Jan 2026 22 Jul 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 4 10.0 9.9 10.0 9 Dec 2025 13 Jul 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 3 10.0 9.9 10.0 13 Nov 2025 27 Apr 2026
GenScript PeptidesCASE #VI-2026-0860 A 3 10.0 10.0 10.0 25 Jan 2026 24 Jul 2026
Sigma-AldrichCASE #VI-2026-0829 A 3 10.0 9.9 10.0 27 Mar 2026 28 Jun 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 10.0 10.0 10.0 24 Apr 2026 27 Jul 2026
SinoPepCASE #VI-2026-0387 A 3 10.0 9.9 10.0 25 Apr 2026 10 Aug 2026
JEEP PeptidesCASE #VI-2026-0457 A 2 10.0 10.0 10.0 25 Apr 2026 3 Jul 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 2 10.0 10.0 10.0 22 Nov 2025 23 Jun 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 10.0 10.0 10.0 2 Mar 2026 22 Jul 2026
AmbioPharmCASE #VI-2026-0177 A 2 10.0 10.0 10.0 6 May 2026 16 May 2026
NUPEPS PeptidesCASE #VI-2026-0896 X 1 10.0 10.0 10.0 20 Jun 2025 20 Jun 2025
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 8 9.9 9.9 10.0 14 Nov 2025 16 Apr 2026
HomopeptideCASE #VI-2026-0760 A 6 9.9 9.9 10.0 24 May 2026 24 May 2026
Kerui PeptidesCASE #VI-2026-0626 A 4 9.9 9.9 10.0 23 May 2026 8 Jul 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 4 9.9 9.9 10.0 6 Mar 2026 8 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 4 9.9 9.9 10.0 5 Apr 2026 12 Jul 2026
Sangon BioCASE #VI-2026-0671 A 3 9.9 9.9 9.9 6 Jan 2026 4 Jul 2026
Hubei JianxiangCASE #VI-2026-0048 A 3 9.9 9.9 10.0 15 Mar 2026 11 Jul 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 2 9.9 9.9 10.0 12 May 2026 13 Jun 2026
QYAOBIOCASE #VI-2026-0861 A 2 9.9 9.9 10.0 25 Nov 2025 22 Jan 2026
PolyPeptide GroupCASE #VI-2026-0143 A 2 9.9 9.9 9.9 12 Dec 2025 13 Feb 2026
AsymchemCASE #VI-2026-0091 A 2 9.9 9.9 10.0 20 Apr 2026 12 Jun 2026
HkRoidsCASE #VI-2026-0784 X 1 9.8 9.8 9.8 3 Jul 2025 3 Jul 2025
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 5 8.9 8.1 9.4 21 May 2026 21 May 2026
Peptide PartnersCASE #VI-2026-0295 X 6 8.8 7.2 10.0 2 Apr 2025 23 May 2026
ZZQ PeptidesCASE #VI-2026-0550 E 2 8.6 7.1 10.0 20 Jun 2025 24 May 2026
YB PeptideCASE #VI-2026-0813 X 1 8.3 8.3 8.3 13 Feb 2025 13 Feb 2025
Glbiochem (Shanghai)CASE #VI-2026-0704 A 7 8.2 6.9 8.9 24 May 2026 24 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 3 8.1 7.8 8.3 24 May 2026 24 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 2 7.8 7.5 8.1 25 May 2026 25 May 2026
Xingtai Pukelai Technology CoCASE #VI-2026-0850 X 1 7.8 7.8 7.8 9 Jun 2025 9 Jun 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 5 7.6 7.1 8.0 24 May 2026 24 May 2026
Loti LabsCASE #VI-2026-0171 X 3 7.3 5.4 9.3 14 Jan 2025 26 Jan 2026
ZhuoYan labCASE #VI-2026-0902 X 2 7.2 6.3 8.1 7 May 2025 23 May 2026
Coastal PeptidesCASE #VI-2026-0958 X 2 5.2 4.7 5.8 27 Feb 2025 20 May 2026
Pharma Grade PeptidesCASE #VI-2026-0208 X 1 4.9 4.9 4.9 24 Apr 2025 24 Apr 2025
Bio PepzCASE #VI-2026-0436 X 1 4.9 4.9 4.9 14 Jan 2025 14 Jan 2025
DeuschemCASE #VI-2026-0004 X 2 3.4 2.2 4.6 3 Jul 2025 21 May 2026
Hebei Chengtong TechnologyCASE #VI-2026-0520 X 1 0.0 0.0 0.0 7 May 2025 7 May 2025

Open any subject to view the batch-level evidence for Testosterone Cypionate Raw alone.